CLOZAPINE MYLAN clozapine 100 mg tablet blister pack

Ülke: Avustralya

Dil: İngilizce

Kaynak: Department of Health (Therapeutic Goods Administration)

Aktif bileşen:

clozapine, Quantity: 100 mg

Mevcut itibaren:

Viatris Pty Ltd

Farmasötik formu:

Tablet, uncoated

Kompozisyon:

Excipient Ingredients: lactose monohydrate; colloidal anhydrous silica; maize starch; purified talc; magnesium stearate; povidone

Uygulama yolu:

Oral

Paketteki üniteler:

100 x 100 mg tablets, 28 tablets, 50 x 100mg tablets

Reçete türü:

(S4) Prescription Only Medicine

Terapötik endikasyonlar:

CLOZAPINE MYLAN is indicated in treatment-resistant schizophrenic patients only, i.e. schizophrenic patients who are non-responsive to, or intolerant of other antipsychotic drugs. Non-responsiveness is defined as a lack of satisfactory clinical improvement despite the use of adequate doses of at least two classes of marketed antipsychotic drugs prescribed for reasonable durations. Intolerance is defined as the impossibility to achieve adequate benefit with other antipsychotic drugs because of severe and untreatable neurological adverse reactions (extrapyramidal side effects or tardive dyskinesia).

Ürün özeti:

Visual Identification: Yellow flat circular tablet with bevelled edge, 10 mm in diameter, angle scored, marked "ZA" on one side and "SANDOZ" on the other.; Container Type: Blister Pack; Container Material: PVC/PVDC/Al; Container Life Time: 5 Years; Container Temperature: Store below 30 degrees Celsius

Yetkilendirme durumu:

Registered

Yetkilendirme tarihi:

2020-01-10